Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Root

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Plos Pathogens|December 20, 2016
Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 TrimerMukta D Khasnis, Konstantine Halkidis, Anshul Bhardwaj, et al.
Bioconjugate Chemistry|October 15, 2016
Site-Specific Polymer Attachment to HR2 Peptide Fusion Inhibitors against HIV-1 Decreases Binding Association Rates and Dissociation Rates Rather Than Binding AffinityMaarten Danial, Angela N Stauffer, Frederik R Wurm, et al.
The Journal of Biological Chemistry|December 2, 2011
Nucleoporin Nup50 stabilizes closed conformation of armadillo repeat 10 in importin α5Ruth A Pumroy, Jonathan D Nardozzi, Darren J Hart, et al.
Plos Pathogens|May 18, 2022
Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 EnvHannah M Schapiro, Mukta D Khasnis, Koree Ahn, et al.
Retrovirology|October 10, 2021
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivatorsShiyu Zhang, Andrew P Holmes, Alexej Dick, et al.
Journal of Immunological Methods|March 4, 2008
Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxinsSharad P Adekar, R Mark Jones, M D Elias, et al.
Hybridoma (2005)|February 26, 2008
A human monoclonal antibody that binds serotype A botulinum neurotoxinSharad P Adekar, R Mark Jones, M D Elias, et al.
Retrovirology|October 24, 2019
Characterization of resistance to a potent D-peptide HIV entry inhibitorAmanda R Smith, Matthew T Weinstock, Amanda E Siglin, et al.
Plos One|August 21, 2008
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chainSharad P Adekar, Tsuyoshi Takahashi, R Mark Jones, et al.
Journal of Virology|August 20, 2010
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistanceBrett D Welch, J Nicholas Francis, Joseph S Redman, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Plos Pathogens|December 20, 2016
Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 TrimerMukta D Khasnis, Konstantine Halkidis, Anshul Bhardwaj, et al.
Bioconjugate Chemistry|October 15, 2016
Site-Specific Polymer Attachment to HR2 Peptide Fusion Inhibitors against HIV-1 Decreases Binding Association Rates and Dissociation Rates Rather Than Binding AffinityMaarten Danial, Angela N Stauffer, Frederik R Wurm, et al.
The Journal of Biological Chemistry|December 2, 2011
Nucleoporin Nup50 stabilizes closed conformation of armadillo repeat 10 in importin α5Ruth A Pumroy, Jonathan D Nardozzi, Darren J Hart, et al.
Plos Pathogens|May 18, 2022
Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 EnvHannah M Schapiro, Mukta D Khasnis, Koree Ahn, et al.
Retrovirology|October 10, 2021
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivatorsShiyu Zhang, Andrew P Holmes, Alexej Dick, et al.
Journal of Immunological Methods|March 4, 2008
Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxinsSharad P Adekar, R Mark Jones, M D Elias, et al.
Hybridoma (2005)|February 26, 2008
A human monoclonal antibody that binds serotype A botulinum neurotoxinSharad P Adekar, R Mark Jones, M D Elias, et al.
Retrovirology|October 24, 2019
Characterization of resistance to a potent D-peptide HIV entry inhibitorAmanda R Smith, Matthew T Weinstock, Amanda E Siglin, et al.
Plos One|August 21, 2008
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chainSharad P Adekar, Tsuyoshi Takahashi, R Mark Jones, et al.
Journal of Virology|August 20, 2010
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistanceBrett D Welch, J Nicholas Francis, Joseph S Redman, et al.
Pageof 3